Renalytix Plc (AIM: RENX)
London flag London · Delayed Price · Currency is GBP · Price in GBX
11.50
-0.75 (-6.12%)
Jan 20, 2025, 3:29 PM GMT+1

Renalytix Revenue

Renalytix had revenue of $522.00K USD in the quarter ending September 30, 2024, with 13.73% growth. This brings the company's revenue in the last twelve months to $2.35M, down -18.70% year-over-year. In the fiscal year ending June 30, 2024, Renalytix had annual revenue of $2.29M, down -32.74%.

Revenue (ttm)
$2.35M
Revenue Growth
-18.70%
P/S Ratio
7.27
Revenue / Employee
$23.06K
Employees
102
Market Cap
38.09M GBP

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Jun 30, 20242.29M-1.11M-32.74%
Jun 30, 20233.40M433.00K14.58%
Jun 30, 20222.97M1.48M99.20%
Jun 30, 20211.49M--
Jun 30, 2020---
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 38.20B
GSK plc 31.31B
Haleon 11.24B
Smith & Nephew 4.46B
ConvaTec Group 1.74B
Hikma Pharmaceuticals 2.39B
HUTCHMED (China) 483.31M
Oxford Nanopore Technologies 167.75M
Revenue Rankings